Showing results (1-10 of 685) with videos related to
Sort By:
Pageof 69
Rheumatic Diseases Clinics of North America|June 1, 2005
Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experienceMurray B Urowitz, Dafna D GladmanCurrent Rheumatology Reports|July 30, 2008
The SLICC inception cohort for atherosclerosisMurray B Urowitz, Dafna D GladmanRheumatic Diseases Clinics of North America|June 1, 2005
Premature atherosclerosis in systemic lupus erythematosusMandana Nikpour, Murray B Urowitz, Dafna D GladmanExpert Opinion on Biological Therapy|January 24, 2013
Systemic lupus erythematosus: an update on current pharmacotherapy and future directionsZahi Touma, Murray B Urowitz, Dafna D GladmanThe Journal of Rheumatology|May 4, 2005
Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLEDominique Ibañez, Dafna D Gladman, Murray B UrowitzThe Journal of Rheumatology|February 3, 2019
Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving StoryMurray B Urowitz, Jiandong Su, Dafna D GladmanThe Journal of Rheumatology|September 11, 2003
Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupusDominique Ibañez, Murray B Urowitz, Dafna D GladmanThe Journal of Rheumatology|February 13, 2002
Systemic lupus erythematosus disease activity index 2000Dafna D Gladman, Dominique Ibañez, Murray B UrowitzCurrent Opinion in Rheumatology|February 2, 2013
Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaignZahi Touma, Dafna D Gladman, Murray B UrowitzSeminars in Arthritis and Rheumatism|November 13, 2018
How can we define low disease activity in systemic lupus erythematosus?Konstantinos Tselios, Dafna D Gladman, Murray B UrowitzPageof 69